CN1107677C - 喜树碱衍生物和制备方法及其作为抗肿瘤剂的应用 - Google Patents

喜树碱衍生物和制备方法及其作为抗肿瘤剂的应用 Download PDF

Info

Publication number
CN1107677C
CN1107677C CN97192493A CN97192493A CN1107677C CN 1107677 C CN1107677 C CN 1107677C CN 97192493 A CN97192493 A CN 97192493A CN 97192493 A CN97192493 A CN 97192493A CN 1107677 C CN1107677 C CN 1107677C
Authority
CN
China
Prior art keywords
compound
formula
hydrogen
compounds
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97192493A
Other languages
English (en)
Chinese (zh)
Other versions
CN1211987A (zh
Inventor
L·默里尼
S·潘科
F·尊尼诺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Nazionale per lo Studio e la Cura die Tumori
Original Assignee
Istituto Nazionale per lo Studio e la Cura die Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1107677(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Istituto Nazionale per lo Studio e la Cura die Tumori filed Critical Istituto Nazionale per lo Studio e la Cura die Tumori
Publication of CN1211987A publication Critical patent/CN1211987A/zh
Application granted granted Critical
Publication of CN1107677C publication Critical patent/CN1107677C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
CN97192493A 1996-02-23 1997-02-19 喜树碱衍生物和制备方法及其作为抗肿瘤剂的应用 Expired - Fee Related CN1107677C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000338A IT1282673B1 (it) 1996-02-23 1996-02-23 Derivati della camptotecina e loro uso come agenti antitumorali
ITMI96A000338 1996-02-23

Publications (2)

Publication Number Publication Date
CN1211987A CN1211987A (zh) 1999-03-24
CN1107677C true CN1107677C (zh) 2003-05-07

Family

ID=11373368

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97192493A Expired - Fee Related CN1107677C (zh) 1996-02-23 1997-02-19 喜树碱衍生物和制备方法及其作为抗肿瘤剂的应用

Country Status (22)

Country Link
US (2) US6130227A (enExample)
EP (1) EP0885230B1 (enExample)
JP (1) JP4171527B2 (enExample)
KR (1) KR100497906B1 (enExample)
CN (1) CN1107677C (enExample)
AT (1) ATE221071T1 (enExample)
AU (1) AU718361B2 (enExample)
BR (1) BR9707622B1 (enExample)
CZ (1) CZ289268B6 (enExample)
DE (1) DE69714220T2 (enExample)
DK (1) DK0885230T3 (enExample)
EE (1) EE03529B1 (enExample)
ES (1) ES2180932T3 (enExample)
HU (1) HUP9900987A3 (enExample)
IL (1) IL125856A (enExample)
IT (1) IT1282673B1 (enExample)
NZ (1) NZ331126A (enExample)
PT (1) PT885230E (enExample)
RU (1) RU2165935C2 (enExample)
SK (1) SK283217B6 (enExample)
UA (1) UA49005C2 (enExample)
WO (1) WO1997031003A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087801B1 (en) * 1998-06-26 2002-01-16 Quanam Medical Corporation Topoisomerase inhibitors for prevention of restenosis
US7105492B2 (en) 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
ES2175919T3 (es) * 1999-03-09 2002-11-16 Sigma Tau Ind Farmaceuti Derivados del camptothecin con actividad antitumoral.
AR025587A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
WO2002083938A2 (en) * 2001-04-11 2002-10-24 Emerald Biostructures, Inc. Screening methods for identifying ligands
RU2319482C2 (ru) * 2001-11-23 2008-03-20 Чугаи Сейяку Кабусики Кайся Способ идентификации противоопухолевых целевых ферментов
JP2005525367A (ja) * 2002-03-01 2005-08-25 フアルマシア・イタリア・エツセ・ピー・アー 塩酸イリノテカンの結晶多形
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
US7067666B2 (en) * 2003-06-27 2006-06-27 Research Triangle Institute 7-substituted camptothecin and camptothecin analogs and methods for producing the same
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
JP5657205B2 (ja) * 2005-12-21 2015-01-21 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 薬物耐性腫瘍の治療
WO2007095389A2 (en) * 2006-02-17 2007-08-23 Novacea, Inc. Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs
CN101033230B (zh) 2006-03-10 2010-12-08 中国科学院上海药物研究所 一类喜树碱衍生物及其应用
ITMI20061474A1 (it) * 2006-07-26 2008-01-27 Indena Spa Derivati della camptotecina ad attivita antitumorale
CN102731516B (zh) * 2011-04-07 2014-07-02 宁波天衡药业股份有限公司 一类具有抗肿瘤活性的喜树碱衍生物
CN104774209B (zh) * 2014-01-15 2018-06-19 上海海和药物研究开发有限公司 一种9-烯丙基喜树碱衍生物的合成方法
WO2023030364A1 (zh) * 2021-09-01 2023-03-09 上海弼领生物技术有限公司 一种喜树碱类化合物、其制备方法和用途
CN120554369A (zh) * 2024-05-24 2025-08-29 深圳微芯生物科技股份有限公司 喜树碱类似物及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088642A2 (en) * 1982-03-10 1983-09-14 Kabushiki Kaisha Yakult Honsha New camptothecin derivatives and process for their preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
US5459269A (en) * 1992-06-18 1995-10-17 North Carolina State University 14-halo-camptothecins
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
CA2262745C (en) * 1996-08-19 2006-04-04 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088642A2 (en) * 1982-03-10 1983-09-14 Kabushiki Kaisha Yakult Honsha New camptothecin derivatives and process for their preparation

Also Published As

Publication number Publication date
RU2165935C2 (ru) 2001-04-27
JP4171527B2 (ja) 2008-10-22
SK112798A3 (en) 1999-01-11
EE03529B1 (et) 2001-10-15
WO1997031003A1 (en) 1997-08-28
DE69714220D1 (de) 2002-08-29
CZ289268B6 (cs) 2001-12-12
HUP9900987A3 (en) 2000-01-28
KR19990087110A (ko) 1999-12-15
US6306868B1 (en) 2001-10-23
DE69714220T2 (de) 2002-11-14
EP0885230A1 (en) 1998-12-23
HUP9900987A2 (hu) 1999-08-30
DK0885230T3 (da) 2002-11-18
JP2000505448A (ja) 2000-05-09
EP0885230B1 (en) 2002-07-24
AU718361B2 (en) 2000-04-13
AU1875397A (en) 1997-09-10
BR9707622A (pt) 1999-07-27
EE9800259A (et) 1999-02-15
ATE221071T1 (de) 2002-08-15
US6130227A (en) 2000-10-10
ITMI960338A0 (enExample) 1996-02-23
SK283217B6 (sk) 2003-03-04
CN1211987A (zh) 1999-03-24
IL125856A (en) 2001-08-26
ITMI960338A1 (it) 1997-08-23
ES2180932T3 (es) 2003-02-16
IL125856A0 (en) 1999-04-11
IT1282673B1 (it) 1998-03-31
CZ265298A3 (cs) 1999-01-13
BR9707622B1 (pt) 2010-08-10
PT885230E (pt) 2002-12-31
UA49005C2 (uk) 2002-09-16
KR100497906B1 (ko) 2006-03-09
NZ331126A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
CN1107677C (zh) 喜树碱衍生物和制备方法及其作为抗肿瘤剂的应用
CN1107069C (zh) 用于治疗癌症的喜树碱衍生物和其用途
KR100516593B1 (ko) 고 친유성 캠프토테신 유도체
WO2023015559A1 (en) Macrocycle compounds as inhibitors of ras
CN1123548A (zh) 喜树碱衍生物及其制备方法
BG65032B1 (bg) Производни на камптотецин с антитуморно действие
CN1132836C (zh) 各种片螺素化合物和类似物的合成及中间体
CN87106996A (zh) 喹啉基化合物，它们的制备方法和以其作为有效药物组分的抗癌剂
JP4990620B2 (ja) ７−置換カンプトテシンおよびカンプトテシン類似体ならびにそれらの調製方法
FR2801310A1 (fr) NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
JP2008542428A5 (enExample)
CN1244585C (zh) 甲硅烷基喜树碱和甲硅烷基高喜树碱的合成
CN1071167A (zh) 精神安定剂2-取代的全氢化-1H-吡啶并[1，2-a]吡嗪类化合物
CN1365278A (zh) 作为安全有效抗疟剂的水溶性三噁烷
CN1634928A (zh) 喜树碱衍生物的制备方法
CA2247513C (en) Camptothecin derivatives and the use thereof as antitumor agents
US20220235072A1 (en) Semi-synthetic analogues of epipolythiodioxopiperazine alkaloids
CN1259132A (zh) 化合物
CN1575292A (zh) 20(s)－喜树碱的药学上可接受的盐
CN1390846A (zh) 具有抗病毒、抗癌活性的氨基糖肽类新化合物
CN1827578A (zh) 可用于抗肿瘤的萘醌甲酸的软类似物
CN1164227A (zh) 联苯并咪唑衍生物
CN1125447A (zh) 取代的亚甲二氧基[3′，4′：6，7]中氮茚并[1，2-b]喹啉酮类化合物
EP1556387A1 (fr) Derives de benzo (e) (1,4) oxazino (3,2-g) isoindole substi tues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HK1023344B (en) Pharmaceutically active tricyclic amines

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20030507

Termination date: 20110219